Development of a web application and a mobile app to improve breast cancer patient follow-up.
Together with AIM-Apps in Medicine GmbH, AOK Bayern, DAK Gesundheit and Siemens Betriebskrankenkasse (SBK), under the direction of the Klinikum rechts der Isar of the Technical University of Munich (MRI), BITS GmbH participated in the PRISMA study as a consortium partner for the technical infrastructure and developed the PRISMA portal and the “Meine Busenfreundin” app for this purpose. Thirty breast centers throughout Bavaria are participating in the associated study. PRISMA is funded with 3.46 million from the Innovation Fund of the Federal Joint Committee (GBA).
The tasks of BITS here include all digital aspects, including technical IT project management, IT conception, IT architecture and development of the web portal to manage the study and the implementation of the digital questionnaires within the app “Meine Busenfreundin”.
BITS as consortium partner
“Together with BITS GmbH as technical partner for the development of the PRISMA portal and mobile app, we have successfully started the PRISMA study. We want to use this new form of care to improve the quality of life and treatment adherence of breast cancer patients.”
BITS as consortium partner
“Together with BITS GmbH as technical partner for the development of the PRISMA portal and mobile app, we have successfully started the PRISMA study. We want to use this new form of care to improve the quality of life and treatment adherence of breast cancer patients.”
Challenge
Breast cancer is one of the most common cancers in women, with around 70,000 new cases each year. In most cases, for women with hormone-sensitive breast cancer, treatment is not over even after surgery, chemotherapy and radiation therapy. This is followed by years of taking medication, because with the appropriate anti-hormone therapy, the risk of relapse can be halved. Nevertheless, many women discontinue the medication within the first two years.
The reasons for this are the great psychological stress caused by the disease and the side effects caused by taking the medication.
This is where PRISMA (primary hormone-sensitive breast carcinoma) comes in. The goal is to provide patients with new digital, on-demand care to prevent the risk of relapse.
Realization
As one of the consortium partners, BITS is taking care of the technical realization of the digital infrastructure in the project funded by the Innovation Fund of the Federal Joint Committee (GBA). In addition to IT project management, our tasks include IT conception, IT architecture and development of the web portal to manage the study and the implementation of the digital questionnaires within the app “Meine Busenfreundin”.
The app is connected via an interface to the newly developed, web-based platform PRISMA, to which only the treating breast center has access. If the patient repeatedly makes conspicuous statements, PRISMA informs the breast center. There, a specialist can then contact the patient directly and provide advice.
Initially, this will be investigated in 400 female subjects as part of a study. Half will use the app and the other half will receive conventional follow-up. By comparing these two groups in terms of treatment adherence and quality of life, the benefits of digital care will be examined.
Projektrollen im Überblick
Die Experten/innen der BITS übernahmen folgende Rollen in diesem Projekt.
Tools & Technologien
Folgende Tools und Technologien kamen in diesem Projekt zum Einsatz.
CONTACT
Möchten Sie mehr erfahren?
Sind Sie interessiert daran, mehr über die Möglichkeiten der Digitalisierung in Ihrem Unternehmen zu erfahren? Stehen Sie vor ähnlichen Herausforderungen oder haben konkrete Projekte in ihrem Unternehmen geplant? Kontaktieren Sie uns gerne für eine ausführliche Beratung.
Senden Sie uns gerne direkt eine E-Mail an kontakt@mybits.de – wir freuen uns darauf, mit Ihnen zusammen die Zukunft Ihrer IT-Landschaft zu gestalten!
Sie können auch ein Termin direkt in unserem Kalender vereinbaren.